
In some youths, frequent mood instability—sudden and unpredictable shifts in emotional states—may precede a "conversion" to bipolar disorder (BD). These sudden shifts in emotions can take various…
Read More

On March 19, 2019, the U.S. Food and Drug Administration approved the first-ever drug specifically designed to alleviate the symptoms of postpartum depression. The drug, called brexanolone, acts…
Read More

Many patients with psychotic disorders, including schizophrenia and some cases of major depression and bipolar disorder, experience difficulty establishing relationships and participating in social…
Read More